Antiphospholipid syndrome is an autoimmune disease. It can cause life-threatening blood clots. If you have this condition in pregnancy, your healthcare provider will watch you closely. Medicine can help reduce your risk for blood clots, but they can still happen.
ICD-10 code D68. 61 for Antiphospholipid syndrome is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Most APS patients give birth to healthy babies; however these babies are prone to low birth weight. In some cases aPL may be detected in the baby's blood at birth as a consequence of maternal transmission; however, the antibodies tend to disappear within the first six months and usually do not result in blood clots.
Overall, approximately half of aPL-associated pregnancy losses occur in the first trimester (pre-embryonic and embryonic loss, < 10 weeks of gestation) (75). The diagnosis of APS should be made only with three or more consecutive losses in the absence of other identifiable etiologies.
Antiphospholipid (AN-te-fos-fo-LIP-id) syndrome is a condition in which the immune system mistakenly creates antibodies that attack tissues in the body. These antibodies can cause blood clots to form in arteries and veins. Blood clots can form in the legs, lungs and other organs, such as the kidneys and spleen.
Antiphospholipid antibody with hemorrhagic disorder D68. 312 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 312 became effective on October 1, 2021.
Treatment during pregnancy involves taking daily doses of aspirin or heparin, or a combination of both. This depends on whether you have a history of blood clots and previous complications during pregnancy.
To diagnose APS, the blood needs to be tested for the abnormal antiphospholipid antibodies that increase the risk of blood clots. This requires a blood test specifically designed to look for these antibodies.
Antiphospholipid syndrome (APS) is caused by the body's immune system producing abnormal antibodies called antiphospholipid antibodies. This increases the risk of blood clots developing in the blood vessels, which can lead to serious health problems, such as: deep vein thrombosis (DVT) strokes.
Abstract. Antiphospholipid syndrome (APS) is associated with adverse pregnancy outcomes including preeclampsia, recurrent early pregnancy loss, fetal death, and intrauterine growth restriction. Approximately one third of women with APS will develop preeclampsia during pregnancy.